Marketzone with MT Newswires 2022 | All the news about APELLIS PHARMACEUTICALS, INC. |
| | |
| Analyst Recommendations for APELLIS PHARMACEUTICALS, INC. |
| | |
|
|
| 2022 turnover |
79.1M
–
79.3M | | 2022 net result |
-627M
–
-628M | | trso. net 2022 |
400M
–
401M | | PER 2022 | -11.1x | | 2022 return | – |
| | Capitalization |
7,294M
7,294M
7,310M | | VE / CA 2022 | 87.2x | | VE / CA 2023 | 26.6x | | Number of employees | 476 | | Floating | 84.5% |
|
| Chart APELLIS PHARMACEUTICALS, INC. |
|
Hard :
Period:
|
 | |
Trends Technical Analysis APELLIS PHARMACEUTICALS, INC.
| Short term | Middle term | Long term | | Trends | bullish | bullish | bullish | Evolution of the Income Statement | | Average recommendation | TO BUY | | Number of Analysts | 18 | | Last Closing Price | $66.39 | | Average price target | $76.53 | | Deviation / Average Target | 15.3% |
|
Source link -88
